| Non-AKI | Developing AKI | P |
---|---|---|---|
 | (N = 432) | (N = 49) |  |
Age, years | 57(25) | 61(25) | 0.04 |
Gender male, n (%) | 243(56) | 38(77) | 0.004 |
BMI (kg/m2) | 24.6(4.8) | 25.1(4.4) | 0.67 |
APACHE II | 16(9) | 23(11) | <0.001 |
SOFA | 4(4) | 9(6) | <0.001 |
Admission diagnosis, n (%) | Â | Â | Â |
  Medical | 100(23) | 18(36) | 0.11 |
  Surgical | 215(49) | 20(40) |  |
  Neurological | 117(27) | 11(22) |  |
Renal characteristics | Â | Â | Â |
Baseline SCr (mg/dl) | 0.74(0.3) | 0.85(0.3) | 0.002 |
UP (ml/kg/h) | 1.1(0.8) | 0.9(0.9) | 0.32 |
FB (l) | 1.9(3.0) | 4.3(4.4) | <0.001 |
AKIN-stages, n (%) | Â | Â | Â |
  AKIN-1 |  | 34 |  |
  AKIN-2 |  | 11 |  |
  AKIN-3 |  | 4 |  |
Patients with CVVH, n (%) | Â | 3(6) | Â |
Outcome | Â | Â | Â |
SCr at hospital discharge (mg/dl) | 0.68(0.2) | 0.77(0.6) | 0.002 |
ICU days | 3(5) | 7(11) | <0.001 |
28-day mortality (%) | 53(12) | 15(30) | 0.002 |
Hospital mortality (%) | 59(13) | 17(34) | 0.001 |